WELLINGTON MANAGEMENT GROUP LLP

Wellington Management's 13F portfolio eased to $535.5B in Q1 2026 from $570.7B a quarter earlier, with its highest-conviction selling concentrated in the mega-cap leaders — Apple (-$4.5B), Alphabet (-$4.2B), Nvidia (-$2.9B), and UnitedHealth (-$2.4B). What sets Wellington apart from peers of similar size is its healthcare depth: Eli Lilly (2.31%) and Merck (1.89%) sit among its top names, and Healthcare is the firm's second-largest sleeve at $43.9B. The firm added to Exxon Mobil (+$1.3B) and Honeywell (+$1.26B) and opened fresh stakes including BlackRock, Netflix, Northrop Grumman, and Taiwan Semiconductor. Its whale score of 73 is the highest among the largest filers this quarter.